Nausea vomiting diarrhea and loss of appetite may occur.
Adriamycin side effects breast cancer.
Side effects are common though symptoms such as nausea and vomiting are often well controlled with preventive medications.
Red colored urine for two days after treatment due to the drug s color not bleeding hair loss or thin brittle hair.
To treat advanced stage breast cancer.
Nausea and vomiting can be severe.
Nausea and vomiting may be severe diarrhea loss of appetite missed menstrual periods darkening of your skin or nails weakness tiredness eye redness or.
It works by impairing dna synthesis a crucial feature of cell division and thus is able to target rapidly dividing cells.
Some common side effects of breast cancer treatment are fatigue pain nausea vomiting decreased blood cell counts hair loss and mouth sores.
A problem that occurs when treatment affects healthy tissues or organs.
See also warning section.
Metastatic disease leukemia or lymphoma.
Adriamycin can have a toxic effect on the heart.
Call your doctor or get medical help if any of these side effects or any other side effects bother you or do not go away.
In some cases drug therapy may be needed to.
Upset stomach or throwing up.
Doxorubicin is a type of anti cancer drug called an anthracycline glycoside.
Mouth irritation or mouth sores.
Side effect related to each.
Before surgery to shrink large advanced stage breast cancer tumors.
Side effects may include.
Cancer care ontario is committed to ensuring accessible services and communications to individuals with disabilities.
Color of urine is orange or red for 1 to 2 days after getting adriamycin doxorubicin conventional.
Severe nausea and vomiting nausea and vomiting and alopecia.
Low white blood cell count.
The recommended dose of doxorubicin when used as a single agent is 60 to 75 mg m 2.
Adriamycin is given intravenously.
These are not all of the side effects that may occur.
You should be tested for heart problems before starting to take adriamycin and should be continuously monitored for developing problems during treatment.
1 855 460 2647 tty 416 217 1815 or by email.
To receive any information on this website in an alternate format please contact communications by phone at.
The recommended dose of doxorubicin is 60 mg m 2 administered as an intravenous bolus on day 1 of each 21 day treatment cycle in combination with cyclophosphamide for a total of four cycles see clinical studies 14.
Doxorubicin is given only as an intravenous injectable.
